Search
Celularity Inc
CELUAdd to Watchlist
0.600USD
+0.002+0.37%
Market hours （ET）Quotes delayed by 15 min
17.31MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.37%
5 Days
-14.25%
1 Month
-40.58%
6 Months
-45.94%
Year to Date
-45.94%
1 Year
-69.38%
Key Figures
0.600Open
0.630High
37.55KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.13%Turnover Ratio
0.598Prev. Close
0.600Low
18.91KTurnover
LossP/E Static
-0.45P/B
0.00%Div Yield TTM
-76.43%ROA
4.35052wk High
0.29Volume Ratio
-57.89MNet Profit
28.84MShares
-3.5861EPS TTM
0.47Beta
-6372.60%ROE
0.71052wk Low
5.02%Amplitude
-88.86%Gross Margin
17.31MMarket Cap
-7.48Reward/Risk
5.90%Risk Rate
TradingKey Stock Score of Celularity Inc
Currency: USD Updated: 2026-06-30Key Insights
Celularity Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 124 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 6.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Celularity Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Celularity Inc Highlights
StrengthsRisks
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 16.60% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 26.55M.
Overvalued
The company’s latest PE is -0.17, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 3.75M shares, decreasing 6.45% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
6.000
Target Price
+889.61%
Upside Space
Celularity Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Celularity Inc Info
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.
Ticker SymbolCELU
CompanyCelularity Inc
CEOHariri (Robert J)
Websitehttps://celularity.com/
Related Instruments
-1.49%
-0.37%
-2.91%
-0.27%
-2.02%
-1.47%
-0.83%
+1.49%
-0.28%
-1.08%
+0.15%
-2.10%
-2.34%
-2.99%
+1.79%
0.00%
+0.29%
-1.94%
+0.38%
-0.69%Popular Instruments
52349.200
+152.900 (+0.29%)
29899.600
-325.000 (-1.07%)
7500.400
+18.000 (+0.24%)
15370.000
-225.000 (-1.44%)
69666.000
-1190.000 (-1.68%)
6279.200
-47.800 (-0.76%)
68.538
-1.383 (-1.98%)
294.560
+5.200 (+1.80%)
197.960
-2.130 (-1.06%)
4063.300
+56.020 (+1.40%)
FAQs
What is the current price of Celularity Inc (CELU)?
The current price of Celularity Inc (CELU) is 0.60.
What is the symbol of Celularity Inc?
The ticker symbol of Celularity Inc is CELU.
What is the 52-week high of Celularity Inc?
The 52-week high of Celularity Inc is 4.35.
What is the 52-week low of Celularity Inc?
The 52-week low of Celularity Inc is 0.71.
What is the market capitalization of Celularity Inc?
The market capitalization of Celularity Inc is 17.31M.
What is the Earnings Per Share (EPS TTM) of Celularity Inc (CELU)?
The Earnings Per Share (EPS TTM) of Celularity Inc (CELU) is -3.59.